Comparative statistics by cancer registry
Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
(Bhopal, India, 1991-1995 cases followed-up until 2000)Click on cancer site (ICD-10 code) for comparison
| % | No. of excluded cases | Included cases | |||||||||
| Site | ICD-10 | Total registered | HV | DCO | DCO | No. follow-up | Others | Total | % | No. | % |
| C01-02 | Tongue | 151 | 90.1 | 0.7 | 1 | 20 | 3 | 24 | 15.9 | 127 | 84.1 |
| C03-06 | Oral cavity | 204 | 89.2 | 0.0 | 0 | 32 | 0 | 32 | 15.7 | 172 | 84.3 |
| C12-13 | Hypopharynx | 131 | 92.4 | 0.0 | 0 | 13 | 0 | 13 | 9.9 | 118 | 90.1 |
| C15 | Oesophagus | 189 | 83.1 | 1.6 | 3 | 22 | 1 | 26 | 13.8 | 163 | 86.2 |
| C16 | Stomach | 87 | 65.5 | 0.0 | 0 | 11 | 1 | 12 | 13.8 | 75 | 86.2 |
| C18 | Colon | 52 | 90.4 | 1.9 | 1 | 3 | 0 | 4 | 7.7 | 48 | 92.3 |
| C19-20 | Rectum | 52 | 80.8 | 1.9 | 1 | 11 | 1 | 13 | 25.0 | 39 | 75.0 |
| C32 | Larynx | 70 | 87.1 | 1.4 | 1 | 9 | 0 | 10 | 14.3 | 60 | 85.7 |
| C33-34 | Lung | 253 | 60.5 | 1.6 | 4 | 31 | 2 | 37 | 14.6 | 216 | 85.4 |
| C50 | Breast | 348 | 87.9 | 0.6 | 2 | 84 | 1 | 87 | 25.0 | 261 | 75.0 |
| C53 | Cervix | 380 | 83.4 | 0.3 | 1 | 46 | 1 | 48 | 12.6 | 332 | 87.4 |
| C56 | Ovary | 104 | 82.7 | 0.0 | 0 | 34 | 1 | 35 | 33.7 | 69 | 66.3 |
| C67 | Urinary bladder | 52 | 84.6 | 0.0 | 0 | 6 | 0 | 6 | 11.5 | 46 | 88.5 |
| C82-85+C96 | Non-Hodgkin lymphoma | 60 | 100.0 | 0.0 | 0 | 29 | 1 | 30 | 50.0 | 30 | 50.0 |
| C91 | Lymphoid leukaemia | 45 | 100.0 | 0.0 | 0 | 13 | 0 | 13 | 28.9 | 32 | 71.1 |
| C92-94 | Myeloid leukaemia | 85 | 96.5 | 2.4 | 2 | 8 | 0 | 10 | 11.8 | 75 | 88.2 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table2b: | Number and proportion of cases by vital status and median follow-up (in months) by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Bhopal, India, 1991-1995) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |